13 June 2019

Many women suffer from recurrent vaginal yeast infections. It is unclear why some women are more sensitive to this than others. Researchers at Radboud university medical center discovered that mutations in the SIGLEC15 gene play an important role in this. These mutations disrupt the immune response, wrote the researchers in Science Translational Medicine, published on 12 June.

Publication: Martin Jaeger et all. A systems genomics approach identifies SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis. Science Translational Medicine.

Almost all women will suffer from a vaginal yeast infection at one time in their life. It is rarely dangerous, but it can be stressful because of the itching and pain. The culprit is the fungus Candida albicans, which occurs naturally in warm damp places in the body, along with numerous other bacteria and fungi. Normally, the Candida fungus is quite harmless, but if the natural balance between the microorganisms is disturbed, it can start to grow rampant, resulting in infections.
In three to eight percent of women, these infections recur regularly, on average three times a year. These infections are perfectly treatable, time after time, but there is no definitive solution to this recurring problem. The question as to why some women are sensitive to these infections remains unanswered. Diabetes may play a role in this, just as long-term use of antibiotics or contraceptive pills, but none of these risk factors apply to the majority of women with recurrent infections. The properties of the fungus itself do not provide a conclusive explanation either.
Unknown gene
It may be possible that some women have a genetic predisposition to getting yeast infections. This has been researched before, but only on the basis of a few predefined genes that play a role in the immune response to Candida. This yielded only very few unambiguous results, which is why Martin Jaeger and his colleagues at Radboud university medical center compared the complete genetic profile of 155 women with and 172 women without susceptibility to Candida infections. They discovered that the SIGLEC15 gene plays an important role. “This gene isn't very well known,” explains Jaeger, “so relatively little research has been done. “
The SIGLEC15 gene is active in various immune cells. It produces so-called lectin proteins that can bind to sugar molecules, including sialic acid that is located on the outside of fungal cells. As soon as lectin adheres to the fungus, the immune system can recognise and clean up the fungus. Jaeger: “Due to a defect in the SIGLEC15 gene, the immune cells do not recognise the fungus, and it can continue to grow. This causes more immune cells, but because they still do not recognise the fungus, it keeps coming back. This cycle keeps coming back, which means that the symptoms are not caused by a lack of immune cells, but rather a surplus of them.”
The discovery of the SIGLEC15 gene provides more information about the cause of yeast infections, but does not offer a complete explanation, says Jaeger: "There are probably multiple genes involved in recurrent vaginal yeast infections. Not everyone with this SIGLEC15 gene mutation automatically gets infections. Many factors play a role, but we have now found an important factor that plays a role in recognising the Candida fungus.
For the treatment of vaginal yeast infections, it remains important to inhibit the immune system's overreaction, but Jaeger thinks it is difficult to cure the ailment definitively. “Because there is a genetic component to it, which - unfortunately - is difficult to eliminate.”

Related news items

4,8 million euros for prevention of tuberculosis among people with diabetes in Africa

16 July 2019

Reinout van Crevel and Lindsey te Brake have received European funding of 4.8 million euros to lead an international consortium to screen thousands of people with diabetes in Uganda and Tanzania for TB, and investigate the effect and costs of 3 months preventive treatment for TB.

read more

50.000 grant for Paul de Jonge and Harry Dolstra

15 July 2019

Paul de Jonge and Harry Dolstra, theme Cancer development and immune defense, received a €50.000,- (NWA-IDG) grant for their project regarding cancer immunotherapy.

read more

Handbook of biomarkers and precision medicine a new publication by Alain van Gool

12 July 2019

Alain van Gool published a new handbook on biomarkers and applications in (pre)clinical drug development for precision medicine.

read more

The real impact of menstrual complaints on work and school productivity

8 July 2019

Menstrual period symptoms may be linked to nearly nine days of lost productivity every year, through presenteeism, suggests the largest study of its kind, published in the journal BMJ Open. But the real impact on women and society is underestimated and poorly appreciated, say the researchers.

read more

Successful Summer School by CMBI, TML and Human Genetics

8 July 2019

CMBI, TML and Human Genetics organized a successful Summer School on 'Integrative X-omics Analyses Empowering Personalized Healthcare'.

read more

Walking for science Research by Radboud university medical center and Radboud University during the Vierdaagse (Four Day Marches)

5 July 2019

The Vierdaagse is a unique opportunity to conduct research into physical activity and healthy lifestyle.

read more